Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Oates

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1990
Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complexA Karpas, I K Hewlett, F Hill, et al.
Cornea|December 8, 2011
Role of the TCF4 gene intronic variant in normal variation of corneal endotheliumDavid A Mackey, Nicole M Warrington, Alex W Hewitt, et al.
JBMR Plus|July 14, 2021
Skeletal responses to romosozumab after 12 months of denosumabMichael R McClung, Michael A Bolognese, Jacques P Brown, et al.
The Journal of Biological Chemistry|December 1, 2019
Withdrawal: Suppression of NF-κB survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAILMamta Chawla-Sarkar, Joseph A Bauer, Joseph A Lupica, et al.
The Journal of Biological Chemistry|July 26, 2003
Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAILMamta Chawla-Sarkar, Joseph A Bauer, Joseph A Lupica, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 15, 2022
Romosozumab and antiresorptive treatment: the importance of treatment sequenceFelicia Cosman, David L Kendler, Bente L Langdahl, et al.
Ophthalmic Genetics|January 11, 2013
Raine eye health study: design, methodology and baseline prevalence of ophthalmic disease in a birth-cohort study of young adultsSeyhan Yazar, Hannah Forward, Charlotte M McKnight, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2021
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trialJacques P Brown, Klaus Engelke, Tony M Keaveny, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1990
Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complexA Karpas, I K Hewlett, F Hill, et al.
Cornea|December 8, 2011
Role of the TCF4 gene intronic variant in normal variation of corneal endotheliumDavid A Mackey, Nicole M Warrington, Alex W Hewitt, et al.
JBMR Plus|July 14, 2021
Skeletal responses to romosozumab after 12 months of denosumabMichael R McClung, Michael A Bolognese, Jacques P Brown, et al.
The Journal of Biological Chemistry|December 1, 2019
Withdrawal: Suppression of NF-κB survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAILMamta Chawla-Sarkar, Joseph A Bauer, Joseph A Lupica, et al.
The Journal of Biological Chemistry|July 26, 2003
Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAILMamta Chawla-Sarkar, Joseph A Bauer, Joseph A Lupica, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 15, 2022
Romosozumab and antiresorptive treatment: the importance of treatment sequenceFelicia Cosman, David L Kendler, Bente L Langdahl, et al.
Ophthalmic Genetics|January 11, 2013
Raine eye health study: design, methodology and baseline prevalence of ophthalmic disease in a birth-cohort study of young adultsSeyhan Yazar, Hannah Forward, Charlotte M McKnight, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2021
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trialJacques P Brown, Klaus Engelke, Tony M Keaveny, et al.
Pageof 20